Search research articles
Contact Us
Filters
Showing results (141-150 of 148) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 148 results.
Cancer Treatment Reports
|
February 1, 1987
High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study
D L Trump, P J Elson, E C Borden, et al.
Leukemia
|
June 6, 2008
Clinical and biological significance of RAS mutations in multiple myeloma
W J Chng, N Gonzalez-Paz, T Price-Troska, et al.
Leukemia & Lymphoma
|
May 26, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma
R P Gale, R E Park, R W Dubois, et al.
Leukemia
|
March 3, 2006
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations
W J Chng, R Santana-Dávila, S A Van Wier, et al.
Leukemia Research
|
August 23, 2005
Ploidy status rarely changes in myeloma patients at disease progression
W J Chng, J M Winkler, P R Greipp, et al.
The American Journal of Medicine
|
October 1, 1980
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group
W D Dewys, C Begg, P T Lavin, et al.
Controlled Clinical Trials
|
February 24, 2001
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
P C Prorok, G L Andriole, R S Bresalier, et al.
Leukemia
|
January 1, 1996
Chemotherapy versus transplants for acute myelogenous leukemia in second remission
R P Gale, M M Horowitz, J K Rees, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 148) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 148 results.
Cancer Treatment Reports
|
February 1, 1987
High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study
D L Trump, P J Elson, E C Borden, et al.
Leukemia
|
June 6, 2008
Clinical and biological significance of RAS mutations in multiple myeloma
W J Chng, N Gonzalez-Paz, T Price-Troska, et al.
Leukemia & Lymphoma
|
May 26, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma
R P Gale, R E Park, R W Dubois, et al.
Leukemia
|
March 3, 2006
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations
W J Chng, R Santana-Dávila, S A Van Wier, et al.
Leukemia Research
|
August 23, 2005
Ploidy status rarely changes in myeloma patients at disease progression
W J Chng, J M Winkler, P R Greipp, et al.
The American Journal of Medicine
|
October 1, 1980
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group
W D Dewys, C Begg, P T Lavin, et al.
Controlled Clinical Trials
|
February 24, 2001
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
P C Prorok, G L Andriole, R S Bresalier, et al.
Leukemia
|
January 1, 1996
Chemotherapy versus transplants for acute myelogenous leukemia in second remission
R P Gale, M M Horowitz, J K Rees, et al.
Page
of 15